LSE - Delayed Quote GBp

ECO Animal Health Group plc (EAH.L)

Compare
65.50
+1.50
+(2.34%)
At close: November 26 at 2:36 PM GMT
Loading Chart for EAH.L
DELL
  • Previous Close 64.00
  • Open 65.50
  • Bid 63.00 x --
  • Ask 68.00 x --
  • Day's Range 64.05 - 67.75
  • 52 Week Range 60.00 - 135.00
  • Volume 40,870
  • Avg. Volume 87,786
  • Market Cap (intraday) 45.77M
  • Beta (5Y Monthly) 0.03
  • PE Ratio (TTM) 32.75
  • EPS (TTM) 0.02
  • Earnings Date Nov 28, 2024 - Dec 2, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 23, 2021
  • 1y Target Est 1.76

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, lices, and mange in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

www.ecoanimalhealthgroupplc.com

227

Full Time Employees

March 31

Fiscal Year Ends

Recent News: EAH.L

View More

Performance Overview: EAH.L

Trailing total returns as of 11/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EAH.L
39.63%
FTSE 100
6.79%

1-Year Return

EAH.L
39.07%
FTSE 100
10.29%

3-Year Return

EAH.L
59.06%
FTSE 100
12.97%

5-Year Return

EAH.L
68.71%
FTSE 100
11.66%

Compare To: EAH.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EAH.L

View More

Valuation Measures

Annual
As of 11/25/2024
  • Market Cap

    43.37M

  • Enterprise Value

    25.02M

  • Trailing P/E

    42.11

  • Forward P/E

    59.17

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.49

  • Price/Book (mrq)

    0.52

  • Enterprise Value/Revenue

    0.28

  • Enterprise Value/EBITDA

    3.83

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.17%

  • Return on Assets (ttm)

    2.14%

  • Return on Equity (ttm)

    2.13%

  • Revenue (ttm)

    89.42M

  • Net Income Avi to Common (ttm)

    1.05M

  • Diluted EPS (ttm)

    0.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    22.37M

  • Total Debt/Equity (mrq)

    4.31%

  • Levered Free Cash Flow (ttm)

    4.49M

Research Analysis: EAH.L

View More

Company Insights: EAH.L

Research Reports: EAH.L

View More

People Also Watch